Baxter sees Q3 adjusted EPS 78c-80c, consensus 80c

Sees Q3 revenue up 2%, consensus $3.86B. The company said, “The company expects third-quarter sales growth from continuing operations of approximately 2% on a reported basis and 1% on a constant currency basis. The company expects third-quarter adjusted earnings in aggregate (including discontinued operations) of $0.78 to $0.80 per diluted share and adjusted earnings from continuing operations of $0.65 to $0.67 per diluted share.”